Publication | Closed Access

The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism

Neuroimaging ModalityParkinson DiseasePresynaptic ParkinsonismStriatal Dopamine TransportersNeuroimagingClinical BenefitNeuroscienceNeurologyDopamineBrain ImagingMedicine